P092 Apatinib Reverses Paclitaxel Resistance in Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Apatinib Inhibits Macrophage-Mediated Epithelial–mesenchymal Transition in Lung Cancer

RSC Advances
ChemistryChemical Engineering
2018English

PLGA Nanoparticles Codeliver Paclitaxel and Stat3 siRNA to Overcome Cellular Resistance in Lung Cancer Cells

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2012English

Silibinin Reverses Drug Resistance in Human Small-Cell Lung Carcinoma Cells

Cancer Letters
Cancer ResearchOncology
2013English

Drug Resistance in Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

MicroRNA‑506‑3p Reverses Gefitinib Resistance in Non‑small Cell Lung Cancer by Targeting Yes‑associated Protein 1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma

Journal of Cancer
Oncology
2019English

Furosemide Reverses Multidrug Resistance Status in Bladder Cancer Cells in Vitro

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Enriched Variations in TEKT4 and Breast Cancer Resistance to Paclitaxel

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy